First-in-Human trial tests 'Off-the-Shelf' immune cells to fight aggressive blood cancers
Disease control
Recruiting now
This early-stage study is testing a new combination treatment for adults with specific types of T-cell lymphoma that have returned or not responded to prior therapy. The treatment involves giving patients immune cells from a healthy donor (called natural killer or NK cells) along…
Phase: PHASE1 • Sponsor: John Reneau • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC